Tag Archives: COVID-19 Testing

OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment. Through a […]

Media Alert: Update on NFL COVID-19 Testing

“On August 22, BioReference Laboratories reported an elevated number of positive COVID-19 PCR test results for NFL players and personnel at multiple clubs. The NFL immediately took necessary actions to ensure the safety of the players and personnel. Our investigation indicated that these were most likely false positive results, caused by an isolated contamination during […]

NBA extends community testing program as part of 2019-20 Season Restart in Orlando

NBA NEW YORK – The NBA announced today a new community testing program providing thousands of no-cost COVID-19 PCR tests in Orlando, Fla. and team markets nationwide.  The program, which is a part of NBA Together, the league’s global community and social engagement campaign that aims to support, engage, educate and inspire youth, families and fans […]

Rite Aid Opens New COVID-19 Testing Sites in Michigan and Ohio

Rite Aid CAMP HILL, Pa. (July 29, 2020) – Rite Aid (NYSE: RAD) continues to expand its no-charge COVID-19 testing service with the addition of six drive-through locations opening on July 30 in Michigan and Ohio, through its partnership with the U.S. Department of Health and Human Services (HHS). Like Rite Aid’s existing drive-through testing sites, […]

OPKO Health’s BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees

BioReference initiates COVID-19 testing for all National Basketball Association players and referees, as well as team and league staff for its season restart in Orlando on July 30 ELMWOOD PARK, N.J., July 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), will provide COVID-19 testing oversight for the National Basketball Association’s (NBA) players […]

Major League Soccer Chooses OPKO Health’s BioReference Laboratories to Provide COVID-19 Testing for Players and Employees

BioReference initiates COVID-19 testing for all Major League Soccer players, match officials, and Club and League employees participating in the MLS is Back Tournament MLS will support COVID-19 antibody testing for the Orlando community utilizing BioReference’s community collection program ELMWOOD PARK, N.J., July 09, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), will […]

OPKO Health’s BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility Employees

Based on internal data, 29% of nursing home employees tested positive for antibodies Since the beginning of the COVID-19 pandemic, BioReference has performed 222,000 COVID-19 PCR and 3,500 antibody tests in over 350 facilities ELMWOOD PARK, N.J., July 1, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR […]

OPKO Health’s BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies

BioReference will broaden availability of serological antibody tests to states, hospitals and healthcare organizations throughout the United States ELMWOOD PARK, N.J., April 29, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Antibody testing […]

OPKO Health’s BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)

ELMWOOD PARK, N.J., April 6, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. “Our goal is to maintain the current 24 hour turnaround time for these patients,” said Jon R. Cohen, M.D., Executive Chairman of […]

OPKO Health’s BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test

COVID-19 test will aid healthcare professionals and public health authorities to identify patients infected with COVID-19 ELMWOOD PARK, N.J., March 05, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will offer a test for the novel coronavirus (2019-nCoV), a contagious virus that causes respiratory infection and has shown evidence of human-to-human […]